danazol has been researched along with Angiogenesis, Pathologic in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Czyż, M; Duechler, M; Kowalczyk-Amico, K; Suzin, J; Szubert, M; Szuławska, A | 1 |
Burney, RO; Farrell, ME; Keyser, EA; Langan, KL; Salyer, BA | 1 |
Okamura, T; Shimoda, K | 1 |
Fujimoto, J; Hori, M; Ichigo, S; Tamaya, T | 1 |
2 review(s) available for danazol and Angiogenesis, Pathologic
Article | Year |
---|---|
Endometriosis: translation of molecular insights to management.
Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Combined Modality Therapy; Contraceptives, Oral, Combined; Cytokines; Danazol; Disease Management; Endometriosis; Endometrium; Estradiol; Female; Gene Expression Regulation; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Inflammation; Laparoscopy; Macrophage Activation; Neovascularization, Pathologic; NF-kappa B; Ovulation Inhibition; Pelvic Pain; Progesterone; Progestins; Randomized Controlled Trials as Topic | 2014 |
[Primary chronic myelofibrosis in the Japanese population].
Topics: Animals; Antigens, CD34; Asian People; Chromosome Aberrations; Chronic Disease; Cytokines; Danazol; Hematopoietic Stem Cell Transplantation; Humans; Interferon-alpha; Japan; Neovascularization, Pathologic; Primary Myelofibrosis; Prognosis; Severity of Illness Index; Signal Transduction; Splenectomy | 2005 |
2 other study(ies) available for danazol and Angiogenesis, Pathologic
Article | Year |
---|---|
Evaluation of selected angiogenic and inflammatory markers in endometriosis before and after danazol treatment.
Topics: Ascitic Fluid; Biomarkers; C-Reactive Protein; CA-125 Antigen; Danazol; Endometriosis; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Inflammation; Interleukin-1beta; Interleukin-8; Neovascularization, Pathologic; Pain Measurement; Platelet-Derived Growth Factor; Real-Time Polymerase Chain Reaction; Sensitivity and Specificity; Vascular Endothelial Growth Factor A | 2014 |
Antiestrogenic compounds inhibit estrogen-induced expression of fibroblast growth factor family (FGF-1, 2, and 4) mRNA in well-differentiated endometrial cancer cells.
Topics: Adenocarcinoma; Cell Differentiation; Danazol; Endometrial Neoplasms; Estradiol; Estrogen Antagonists; Female; Fibroblast Growth Factors; Humans; Hydrocortisone; Kinetics; Neovascularization, Pathologic; Polymerase Chain Reaction; RNA, Messenger; Templates, Genetic; Tetrahydrocortisol; Tumor Cells, Cultured | 1997 |